2.5% reduction in the overall cost
of access care. Savings occurred chiefly in the prosthetic
access group and resulted from reduction in the number of
invasive procedures, central catheters, and hospitalizations.
Therefore, and despite the imprecision of evidence, surveillance of accesses may be justified.
5.2. Values and preferences
These recommendations place higher value on preventing access thrombosis and the associated cost, hospitalization, morbidity, and burdens and lower values on inconvenience and